ERBITUX Trademark

Trademark Overview

On Tuesday, April 4, 2000, a trademark application was filed for ERBITUX with the United States Patent and Trademark Office. The USPTO has given the ERBITUX trademark a serial number of 76018914. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, August 21, 2024. This trademark is owned by ImClone Systems Incorporated. The ERBITUX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation, namely, monoclonal antibody for the treatment of cancer
erbitux

General Information

Serial Number76018914
Word MarkERBITUX
Filing DateTuesday, April 4, 2000
Status800 - REGISTERED AND RENEWED
Status DateWednesday, August 21, 2024
Registration Number2865372
Registration DateTuesday, July 20, 2004
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 6, 2001

Trademark Statements

Goods and Servicespharmaceutical preparation, namely, monoclonal antibody for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 29, 2000
Primary Code005
First Use Anywhere DateThursday, February 19, 2004
First Use In Commerce DateThursday, February 19, 2004

Trademark Owner History

Party NameImClone LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10016
Party NameImClone Systems Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameImClone Systems Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014
Party NameImClone Systems Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events

Event DateEvent Description
Tuesday, March 6, 2001PUBLISHED FOR OPPOSITION
Sunday, September 10, 2000ASSIGNED TO EXAMINER
Monday, September 11, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2001NOTICE OF PUBLICATION
Tuesday, January 7, 2003SOU EXTENSION 4 FILED
Tuesday, May 29, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 25, 2001SOU EXTENSION 1 FILED
Tuesday, July 17, 2001SOU EXTENSION 1 GRANTED
Thursday, December 13, 2001SOU EXTENSION 2 FILED
Tuesday, January 22, 2002SOU EXTENSION 2 GRANTED
Friday, July 5, 2002SOU EXTENSION 3 FILED
Friday, July 5, 2002SOU EXTENSION 3 GRANTED
Friday, July 26, 2002PAPER RECEIVED
Tuesday, January 7, 2003PAPER RECEIVED
Tuesday, April 29, 2003SOU EXTENSION 4 GRANTED
Tuesday, July 20, 2004REGISTERED-PRINCIPAL REGISTER
Friday, June 13, 2003PAPER RECEIVED
Friday, June 13, 2003SOU EXTENSION 5 FILED
Friday, June 13, 2003SOU EXTENSION 5 GRANTED
Thursday, March 11, 2004PAPER RECEIVED
Thursday, March 11, 2004USE AMENDMENT FILED
Thursday, March 11, 2004STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 30, 2004CASE FILE IN TICRS
Thursday, April 22, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 18, 2014TEAS SECTION 8 & 9 RECEIVED
Thursday, March 20, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 4, 2009ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, June 3, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 3, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 2, 2010TEAS SECTION 8 & 15 RECEIVED
Friday, July 23, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 23, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 18, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 18, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 6, 2024TEAS SECTION 8 & 9 RECEIVED
Wednesday, August 21, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 21, 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Wednesday, August 21, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, August 21, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, July 20, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, June 28, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, June 28, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, June 28, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, June 28, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

erbitux treatment cancer antibody monoclonal preparation namely pharmaceutical